
Olema insiders sell millions amid analyst upgrades now
United States — Olema Pharmaceuticals executives sold shares between December 19 and December 23, 2025, according to Securities and Exchange Commission filings. Chief Medical Officer Naseem Zojwalla sold $7.5 million of common stock and exercised options; Director Ian T. Clark sold $7.87 million and exercised options; David Myles sold about...








